HIGHLIGHTS
- who: Lei Ke and Ruxu You from the Department of Pharmacy, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Wuhan, China have published the research work: Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C: A Systematic Review, in the Journal: (JOURNAL) of 31/Dec/2020
- what: Since EBR/GZR entered the market, more and more studies focused on its efficacy, safety, and costeffectiveness, which have provided massive evidence for a deeper understanding. Data Synthesis To summarize and evaluate the aims, methods, settings, and results of the studies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.